|
CDC42SE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.545510E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.461900E-03 |
| Normal-vs-Stage2 |
7.301000E-01 |
| Normal-vs-Stage3 |
3.194000E-01 |
| Normal-vs-Stage4 |
3.739900E-02 |
| Stage1-vs-Stage2 |
4.975300E-03 |
| Stage1-vs-Stage3 |
4.944300E-02 |
| Stage1-vs-Stage4 |
9.826200E-01 |
| Stage2-vs-Stage3 |
2.062800E-01 |
| Stage2-vs-Stage4 |
2.745600E-02 |
| Stage3-vs-Stage4 |
1.889230E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.911600E-02 |
| Normal-vs-AfricanAmerican |
4.504900E-03 |
| Normal-vs-Asian |
7.439300E-03 |
| Caucasian-vs-AfricanAmerican |
1.548450E-01 |
| Caucasian-vs-Asian |
1.364010E-01 |
| AfricanAmerican-vs-Asian |
8.212400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.266580E-01 |
| Normal-vs-Female |
9.959600E-03 |
| Male-vs-Female |
3.264000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.136110E-03 |
| Normal-vs-Age(41-60Yrs) |
1.271420E-01 |
| Normal-vs-Age(61-80Yrs) |
4.555400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.736400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.631700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.122210E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.963400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.879600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.634000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.121000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.290470E-02 |
| Classical-VS-Follicular |
3.7962000000058E-05 |
| Classical-VS-Other |
1.241000E-01 |
| Classical-VS-Normal |
1.257080E-03 |
| Tall-VS-Follicular |
8.230200E-01 |
| Tall-VS-Other |
7.788000E-01 |
| Tall-VS-Normal |
9.307200E-01 |
| Follicular-VS-Other |
9.016600E-01 |
| Follicular-VS-Normal |
8.495000E-01 |
| Other-VS-Normal |
8.049400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.558000E-01 |
| Normal-vs-N1 |
3.989700E-02 |
| N0-vs-N1 |
9.702500E-02 |
|
|
